Clinical Trial Update: Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells [Phase 1]

View source ↗

Summary

This update covers an early Phase 1 clinical trial evaluating autologous bone marrow-derived mononuclear cells for treating severe limb ischemia (critical limb …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous bone marrow-derived mononuclear cells (bone marrow-derived mononuclear cells)

Snippet

Sponsor: Odense University Hospital | Conditions: Ischemia | Phase 1 | Status: UNKNOWN